TIGIT and myeloid sarcoma: Together with the inverse correlation between TIGIT+ B cells and CCR6+ cTfh cells, we found that the impaired expression of TIGIT on activated B cells drove the expansion of Th17-like cTfh cells, suggesting a dysregulated loop leading to continued immune activation in patients with MS.